Related Experiment Videos
Glycosphingolipid antibodies in serum in patients with sciatica
Helena Brisby1, Federico Balagué, Dominique Schafer
1Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden. helena.brisby@orthop.gu.se
Spine
|February 13, 2002
Summary
Elevated glycosphingolipid antibodies were found in most sciatica patients, suggesting immune system activation in this condition. This autoimmune response may play a role in the pathophysiology of sciatica and disc herniation.
Area of Science:
- Neurology
- Immunology
- Biochemistry
Background:
- Glycosphingolipid antibodies are elevated in autoimmune neurological diseases.
- Sciatica and disc herniation involve the nervous system, suggesting a potential autoimmune component.
Purpose of the Study:
- To investigate the immunologic response in sciatica patients by analyzing circulating autoantibodies against glycosphingolipids.
- To correlate autoantibody levels with clinical and imaging findings in sciatica patients.
Main Methods:
- Serum antibody titers against 10 glycosphingolipids were measured using enzyme-linked immunosorbent assay (ELISA).
- Three patient groups were studied: acute sciatica, a 4-year follow-up of sciatica patients, and patients undergoing discectomy.
- Antibody titers were compared to a healthy population to identify pathological levels.
Main Results:
- Increased glycosphingolipid antibodies were detected in 71% of acute sciatica patients and 61% at 4-year follow-up.
- 54% of patients undergoing discectomy showed elevated antibody levels.
- In acute sciatica patients, positive neurologic findings correlated with increased antibodies against 3'LM1 and GD1a.
Conclusions:
- The presence of glycosphingolipid antibodies suggests immune system activation in sciatica and disc herniation.
- The autoimmune response is not specific to one glycosphingolipid but involves multiple nervous system-associated targets.
- Further research is warranted to explore the pathophysiological and clinical relevance of these autoimmune responses in sciatica.